Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.

Costales AB, Milbourne AM, Rhodes HE, Munsell MF, Wallbillich JJ, Brown J, Frumovitz M, Ramondetta LM, Schmeler KM.

Gynecol Oncol. 2013 Jun;129(3):513-6. doi: 10.1016/j.ygyno.2013.03.015. Epub 2013 Mar 28.

2.

Conservative management of adenocarcinoma in situ of the cervix.

Shin CH, Schorge JO, Lee KR, Sheets EE.

Gynecol Oncol. 2000 Oct;79(1):6-10.

PMID:
11006022
3.

Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.

Munro A, Codde J, Spilsbury K, Stewart CJ, Steel N, Leung Y, Tan J, Salfinger SG, Mohan GR, Semmens JB, Cohen PA.

Acta Obstet Gynecol Scand. 2017 Apr;96(4):432-437. doi: 10.1111/aogs.13110. Epub 2017 Mar 6.

PMID:
28181670
4.
5.

Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.

Lea JS, Shin CH, Sheets EE, Coleman RL, Gehrig PA, Duska LR, Miller DS, Schorge JO.

Gynecol Oncol. 2002 Oct;87(1):129-32.

PMID:
12468353
6.

Factors affecting residual lesion in women with cervical adenocarcinoma in situ after cone excisional biopsy.

Srisomboon J, Kietpeerakool C, Suprasert P, Siriaunkgul S, Khunamornpong S, Prompittayarat W.

Asian Pac J Cancer Prev. 2007 Apr-Jun;8(2):225-8.

7.

Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.

Bull-Phelps SL, Garner EI, Walsh CS, Gehrig PA, Miller DS, Schorge JO.

Gynecol Oncol. 2007 Nov;107(2):316-9. Epub 2007 Aug 8.

PMID:
17689593
8.

Adenocarcinoma in situ of the cervix: management and outcome.

Azodi M, Chambers SK, Rutherford TJ, Kohorn EI, Schwartz PE, Chambers JT.

Gynecol Oncol. 1999 Jun;73(3):348-53.

PMID:
10366458
9.

Fertility-sparing treatment in younger women with adenocarcinoma in situ of the cervix.

van Hanegem N, Barroilhet LM, Nucci MR, Bernstein M, Feldman S.

Gynecol Oncol. 2012 Jan;124(1):72-7. doi: 10.1016/j.ygyno.2011.09.006. Epub 2011 Oct 24.

PMID:
22030403
10.

Clinical outcomes of patients with adenocarcinoma in situ of the cervix treated by conization.

Taylor JS, Panico V, Caputo T, Gerber D, Gupta D, Pirog E, Holcomb K.

Eur J Gynaecol Oncol. 2014;35(6):641-5.

PMID:
25556268
11.

Further study of the management of cervical adenocarcinoma in situ.

Kennedy AW, Biscotti CV.

Gynecol Oncol. 2002 Sep;86(3):361-4.

PMID:
12217762
12.

Predictive value of negative cone margin status for risk of residual disease among women with cervical adenocarcinoma in situ.

Kietpeerakool C, Khunamornpong S, Srisomboon J, Kasunan A, Sribanditmongkol N, Siriaungkul S.

Int J Gynaecol Obstet. 2012 Dec;119(3):266-9. doi: 10.1016/j.ijgo.2012.06.013. Epub 2012 Aug 29.

PMID:
22939281
13.

Comparison of cold knife cone biopsy and loop electrosurgical excision procedure in the management of cervical adenocarcinoma in situ: What is the gold standard?

Munro A, Leung Y, Spilsbury K, Stewart CJ, Semmens J, Codde J, Williams V, O'Leary P, Steel N, Cohen P.

Gynecol Oncol. 2015 May;137(2):258-63. doi: 10.1016/j.ygyno.2015.02.024. Epub 2015 Mar 11.

PMID:
25769659
14.

Management of adenocarcinoma in situ of the uterine cervix: a comparison of loop electrosurgical excision procedure and cold knife conization.

Latif NA, Neubauer NL, Helenowski IB, Lurain JR.

J Low Genit Tract Dis. 2015 Apr;19(2):97-102. doi: 10.1097/LGT.0000000000000055.

PMID:
25089550
15.

Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.

Ostör AG, Duncan A, Quinn M, Rome R.

Gynecol Oncol. 2000 Nov;79(2):207-10.

PMID:
11063645
16.

Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.

Tierney KE, Lin PS, Amezcua C, Matsuo K, Ye W, Felix JC, Roman LD.

Am J Obstet Gynecol. 2014 Apr;210(4):366.e1-366.e5. doi: 10.1016/j.ajog.2013.12.030. Epub 2013 Dec 24.

PMID:
24370689
17.
18.

Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix.

McHale MT, Le TD, Burger RA, Gu M, Rutgers JL, Monk BJ.

Obstet Gynecol. 2001 Nov;98(5 Pt 1):726-31.

PMID:
11704160
19.

Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.

Denehy TR, Gregori CA, Breen JL.

Obstet Gynecol. 1997 Jul;90(1):1-6.

PMID:
9207802
20.

Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.

Poynor EA, Barakat RR, Hoskins WJ.

Gynecol Oncol. 1995 May;57(2):158-64. Review.

PMID:
7729727

Supplemental Content

Support Center